We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Company Streamlines Detecting, Diagnosing, and Tracking Infectious Disease

By LabMedica International staff writers
Posted on 01 Apr 2014
A company is using its DNA analysis technology in major global collaborations aimed at curbing the spread of viruses such as H1N1 or avian flu, in real time.

The Jerusalem-based subsidiary of Azure PCR (Jerusalem, Israel) has streamlined the process of detecting, diagnosing, and tracking infectious diseases. More...
The company is participating in the largest-ever child health study, the Johns Hopkins (Baltimore, MD, USA)-based PERCH (Pneumonia Etiology Research for Child Health. This multicountry study of hospitalized pediatric patients with severe pneumonia aims to advance new lab techniques in order to better determine causes and risk factors, as well as guide the development of new vaccines and treatments.

The Israeli company’s role in this USD 260 million study is its unique capability for fast and automated data analysis. At this early stage, however, the company is not focusing on consumer application but on using its automatic DNA analysis technology in major global collaborations aimed at curbing the spread of viruses such as H1N1 or avian flu, in real time.

There are three steps to the process: extracting the DNA from a urine or blood sample, testing the DNA, and analyzing the results. The first two steps were automated before Azure PCR came on the scene. Real-time polymerase chain reaction (PCR) is the most popular molecular diagnostic technique in use today, accounting for more than USD 2.8 billion in sales. The breakthrough is automating the analysis step—greatly speeding up the process, removing the need for specially trained technicians (a particularly acute issue for developing countries where skilled professionals can be hard to find), and eliminating room for error in interpreting results.

CEO of Azure PCR, Aron Cohen said, “We make the subjective objective. We can provide standardized results without the need for skilled personnel. With major global pandemics such as SARS and swine flu, we saw a 6- to 18-month lag in diseases that start[ed] in developing nations until spreading to the West, so being able to track these in real time can make prevention through vaccination and other methods possible,” Cohen explained.

“Putting early warning systems in place can improve people’s lives and cut down on the cost of universal healthcare. If we know there is a disease spreading from a town and can map its distribution patterns, targeted vaccination can prevent it from spreading. Prevention is always better than cure.”

Related Links:

Azurepcr
Johns Hopkins 



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Clinical Chemistry

view channel
Image: The steps involved in the electric field-induced capture and release (EFIRM) assay (Photo courtesy of UCLA School of Dentistry)

Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation

Early detection of cancer and other serious diseases is crucial for effective treatment and improved outcomes, yet current diagnostic methods often involve invasive procedures and complex sample preparation.... Read more

Molecular Diagnostics

view channel
Image: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is FDA-cleared for use in diagnosing Alzheimer’s (Photo courtesy of Fujirebio)

First FDA Cleared Blood Test for Alzheimer’s Diagnosis Marks Turning Point in Early Detection

Alzheimer’s disease is a progressive form of dementia that affects memory, cognition, and behavior, eventually interfering with daily activities. Early and accurate diagnosis is essential to improving... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.